Atopic Disease, Particularly Asthma, Linked to Decreased Risk of COVID-19 Infection in UK Adults
Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.
The Obesity Drug Pipeline: 10 Questions on Rx Development
Take this quick quiz to test your knowledge of recent advances most likely to have an impact on weight management in your practice.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Certain Cardiovascular Conditions, Risks May be Worse for Cognition in Middle-aged Women
A Mayo Clinic study found certain cardiovascular conditions and risk factors are more strongly associated with cognitive decline in middle-aged women than men.
Platelet-rich Plasma Injections for Osteoarthritis: How Effective Are They?
Platelet-rich plasma, in theory, seems like a logical and potentially beneficial treatment for osteoarthritis. Our pain expert reviews 2 recent studies that are telling.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
Pandemic-induced Sleep Disturbance Affects More than Half of US Adults
"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.
New Study Suggests Obesity is Modifiable Risk Factor for Severe COVID-19 Infection
Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
American Diabetes Association Publishes Standards of Medical Care for 2022
The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
FDA Authorizes Use of Pfizer COVID-19 Vaccine Booster Dose in Children Aged 12 to 15 Years
Pending endorsement from the CDC, adolescents can now get a booster dose of the Pfizer-BioNTech vaccine, as authorized by an amendment to the original FDA EUA for the vaccine.
FDA approves HIV pre-exposure preventive injection
Cabotegravir extended-release injectable suspension is the first injectable PrEP to receive FDA approval and is given only every 2 months.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
The CDC Recommends Pfizer, Moderna COVID Vaccines over J&J
The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.
Continuous Glucose Monitoring for Type 2 Diabetes in Primary Care: 2021 Research Review
Continuous glucose monitoring for type 2 diabetes patients is gaining exposure in the literature with positive evidence accumulating. Examples follow.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
Racial Disparities in Use of Diabetes Technology Widen among Medicare Enrollees
While use of insulin pumps and CGM increased over a 3-year study period for all racial-ethnic groups, the inequities were significant between White adults and all others.
